ABBVIE INC (1ABBV.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1ABBV - US00287Y1091 - Common Stock
194.2 EUR
-6.8 (-3.38%)
Taking everything into account, 1ABBV scores 5 out of 10 in our fundamental rating. 1ABBV was compared to 81 industry peers in the Biotechnology industry. While 1ABBV is still in line with the averages on profitability rating, there are concerns on its financial health. 1ABBV has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
1ABBV had positive earnings in the past year.
1ABBV had a positive operating cash flow in the past year.
1ABBV had positive earnings in each of the past 5 years.
In the past 5 years 1ABBV always reported a positive cash flow from operatings.
1.2 Ratios
1ABBV's Return On Assets of 2.71% is fine compared to the rest of the industry. 1ABBV outperforms 76.62% of its industry peers.
1ABBV has a Return On Invested Capital of 13.81%. This is amongst the best in the industry. 1ABBV outperforms 90.91% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 1ABBV is in line with the industry average of 13.22%.
The 3 year average ROIC (13.67%) for 1ABBV is below the current ROIC(13.81%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.71% | ||
| ROE | N/A | ||
| ROIC | 13.81% |
ROA(3y)5.07%
ROA(5y)5.21%
ROE(3y)80.76%
ROE(5y)70.31%
ROIC(3y)13.67%
ROIC(5y)12.68%
1.3 Margins
1ABBV's Profit Margin of 6.38% is amongst the best of the industry. 1ABBV outperforms 80.52% of its industry peers.
In the last couple of years the Profit Margin of 1ABBV has declined.
With an excellent Operating Margin value of 31.27%, 1ABBV belongs to the best of the industry, outperforming 90.91% of the companies in the same industry.
1ABBV's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 70.93%, 1ABBV is in the better half of the industry, outperforming 64.94% of the companies in the same industry.
In the last couple of years the Gross Margin of 1ABBV has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 31.27% | ||
| PM (TTM) | 6.38% | ||
| GM | 70.93% |
OM growth 3Y-5.46%
OM growth 5Y-6.52%
PM growth 3Y-28.3%
PM growth 5Y-20.42%
GM growth 3Y0.39%
GM growth 5Y-1.92%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so 1ABBV is still creating some value.
Compared to 1 year ago, 1ABBV has about the same amount of shares outstanding.
The number of shares outstanding for 1ABBV has been increased compared to 5 years ago.
Compared to 1 year ago, 1ABBV has a worse debt to assets ratio.
2.2 Solvency
1ABBV has an Altman-Z score of 2.40. This is not the best score and indicates that 1ABBV is in the grey zone with still only limited risk for bankruptcy at the moment.
1ABBV has a better Altman-Z score (2.40) than 63.64% of its industry peers.
The Debt to FCF ratio of 1ABBV is 3.86, which is a good value as it means it would take 1ABBV, 3.86 years of fcf income to pay off all of its debts.
1ABBV has a better Debt to FCF ratio (3.86) than 79.22% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 3.86 | ||
| Altman-Z | 2.4 |
ROIC/WACC1.52
WACC9.09%
2.3 Liquidity
1ABBV has a Current Ratio of 0.74. This is a bad value and indicates that 1ABBV is not financially healthy enough and could expect problems in meeting its short term obligations.
1ABBV has a worse Current ratio (0.74) than 76.62% of its industry peers.
A Quick Ratio of 0.61 indicates that 1ABBV may have some problems paying its short term obligations.
1ABBV's Quick ratio of 0.61 is on the low side compared to the rest of the industry. 1ABBV is outperformed by 77.92% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.74 | ||
| Quick Ratio | 0.61 |
3. Growth
3.1 Past
The earnings per share for 1ABBV have decreased by -1.03% in the last year.
Measured over the past 5 years, 1ABBV shows a small growth in Earnings Per Share. The EPS has been growing by 2.51% on average per year.
The Revenue has been growing slightly by 6.05% in the past year.
1ABBV shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.11% yearly.
EPS 1Y (TTM)-1.03%
EPS 3Y-7.24%
EPS 5Y2.51%
EPS Q2Q%12.08%
Revenue 1Y (TTM)6.05%
Revenue growth 3Y0.08%
Revenue growth 5Y11.11%
Sales Q2Q%6.65%
3.2 Future
Based on estimates for the next years, 1ABBV will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.59% on average per year.
Based on estimates for the next years, 1ABBV will show a small growth in Revenue. The Revenue will grow by 7.22% on average per year.
EPS Next Y6.19%
EPS Next 2Y19.88%
EPS Next 3Y16.85%
EPS Next 5Y13.59%
Revenue Next Year8.23%
Revenue Next 2Y8.64%
Revenue Next 3Y8.27%
Revenue Next 5Y7.22%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 21.29 indicates a rather expensive valuation of 1ABBV.
80.52% of the companies in the same industry are more expensive than 1ABBV, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of 1ABBV to the average of the S&P500 Index (26.15), we can say 1ABBV is valued inline with the index average.
1ABBV is valuated correctly with a Price/Forward Earnings ratio of 15.51.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 1ABBV indicates a rather cheap valuation: 1ABBV is cheaper than 87.01% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 36.22. 1ABBV is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.29 | ||
| Fwd PE | 15.51 |
4.2 Price Multiples
1ABBV's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. 1ABBV is cheaper than 77.92% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, 1ABBV is valued cheaply inside the industry as 84.42% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.84 | ||
| EV/EBITDA | 17.28 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1ABBV does not grow enough to justify the current Price/Earnings ratio.
1ABBV has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as 1ABBV's earnings are expected to grow with 16.85% in the coming years.
PEG (NY)3.44
PEG (5Y)8.48
EPS Next 2Y19.88%
EPS Next 3Y16.85%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.87%, 1ABBV has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 10.20, 1ABBV pays a better dividend. On top of this 1ABBV pays more dividend than 94.81% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.32, 1ABBV pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.87% |
5.2 History
The dividend of 1ABBV is nicely growing with an annual growth rate of 7.72%!
Dividend Growth(5Y)7.72%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
1ABBV pays out 304.54% of its income as dividend. This is not a sustainable payout ratio.
The dividend of 1ABBV is growing, but earnings are growing more, so the dividend growth is sustainable.
DP304.54%
EPS Next 2Y19.88%
EPS Next 3Y16.85%
BIT:1ABBV (12/1/2025, 7:00:00 PM)
194.2
-6.8 (-3.38%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners74.42%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap343.07B
Revenue(TTM)58.33B
Net Income(TTM)3.72B
Analysts79.46
Price Target197.82 (1.86%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.87% |
Yearly Dividend5.38
Dividend Growth(5Y)7.72%
DP304.54%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.04%
Min EPS beat(2)0.95%
Max EPS beat(2)1.14%
EPS beat(4)4
Avg EPS beat(4)0.75%
Min EPS beat(4)0.02%
Max EPS beat(4)1.14%
EPS beat(8)7
Avg EPS beat(8)0.76%
EPS beat(12)9
Avg EPS beat(12)0.46%
EPS beat(16)11
Avg EPS beat(16)0.4%
Revenue beat(2)2
Avg Revenue beat(2)0.93%
Min Revenue beat(2)0.63%
Max Revenue beat(2)1.23%
Revenue beat(4)2
Avg Revenue beat(4)0.24%
Min Revenue beat(4)-0.71%
Max Revenue beat(4)1.23%
Revenue beat(8)4
Avg Revenue beat(8)0.36%
Revenue beat(12)5
Avg Revenue beat(12)-0.32%
Revenue beat(16)5
Avg Revenue beat(16)-0.81%
PT rev (1m)4.92%
PT rev (3m)5.18%
EPS NQ rev (1m)-45.1%
EPS NQ rev (3m)-44.14%
EPS NY rev (1m)-12.38%
EPS NY rev (3m)-13.98%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)1.45%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.28%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.29 | ||
| Fwd PE | 15.51 | ||
| P/S | 6.83 | ||
| P/FCF | 21.84 | ||
| P/OCF | 20.66 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 17.28 |
EPS(TTM)9.12
EY4.7%
EPS(NY)12.52
Fwd EY6.45%
FCF(TTM)8.89
FCFY4.58%
OCF(TTM)9.4
OCFY4.84%
SpS28.43
BVpS-0.09
TBVpS-45.26
PEG (NY)3.44
PEG (5Y)8.48
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.71% | ||
| ROE | N/A | ||
| ROCE | 18.72% | ||
| ROIC | 13.81% | ||
| ROICexc | 14.74% | ||
| ROICexgc | 370.81% | ||
| OM | 31.27% | ||
| PM (TTM) | 6.38% | ||
| GM | 70.93% | ||
| FCFM | 31.27% |
ROA(3y)5.07%
ROA(5y)5.21%
ROE(3y)80.76%
ROE(5y)70.31%
ROIC(3y)13.67%
ROIC(5y)12.68%
ROICexc(3y)15.06%
ROICexc(5y)13.91%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)17.54%
ROCE(5y)16.27%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-1.81%
ROICexc growth 5Y-14.87%
OM growth 3Y-5.46%
OM growth 5Y-6.52%
PM growth 3Y-28.3%
PM growth 5Y-20.42%
GM growth 3Y0.39%
GM growth 5Y-1.92%
F-Score6
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 3.86 | ||
| Debt/EBITDA | 2.58 | ||
| Cap/Depr | 12.62% | ||
| Cap/Sales | 1.79% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 72.74% | ||
| Profit Quality | 489.9% | ||
| Current Ratio | 0.74 | ||
| Quick Ratio | 0.61 | ||
| Altman-Z | 2.4 |
F-Score6
WACC9.09%
ROIC/WACC1.52
Cap/Depr(3y)9.59%
Cap/Depr(5y)10.06%
Cap/Sales(3y)1.45%
Cap/Sales(5y)1.5%
Profit Quality(3y)361.43%
Profit Quality(5y)328.91%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.03%
EPS 3Y-7.24%
EPS 5Y2.51%
EPS Q2Q%12.08%
EPS Next Y6.19%
EPS Next 2Y19.88%
EPS Next 3Y16.85%
EPS Next 5Y13.59%
Revenue 1Y (TTM)6.05%
Revenue growth 3Y0.08%
Revenue growth 5Y11.11%
Sales Q2Q%6.65%
Revenue Next Year8.23%
Revenue Next 2Y8.64%
Revenue Next 3Y8.27%
Revenue Next 5Y7.22%
EBIT growth 1Y13.81%
EBIT growth 3Y-5.38%
EBIT growth 5Y3.87%
EBIT Next Year20.95%
EBIT Next 3Y15.22%
EBIT Next 5Y11.27%
FCF growth 1Y-26.45%
FCF growth 3Y-6.75%
FCF growth 5Y6.9%
OCF growth 1Y-24.5%
OCF growth 3Y-6.19%
OCF growth 5Y7.14%
ABBVIE INC / 1ABBV.MI FAQ
Can you provide the ChartMill fundamental rating for ABBVIE INC?
ChartMill assigns a fundamental rating of 5 / 10 to 1ABBV.MI.
Can you provide the valuation status for ABBVIE INC?
ChartMill assigns a valuation rating of 6 / 10 to ABBVIE INC (1ABBV.MI). This can be considered as Fairly Valued.
What is the profitability of 1ABBV stock?
ABBVIE INC (1ABBV.MI) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for 1ABBV stock?
The Price/Earnings (PE) ratio for ABBVIE INC (1ABBV.MI) is 21.29 and the Price/Book (PB) ratio is -2176.88.
Can you provide the financial health for 1ABBV stock?
The financial health rating of ABBVIE INC (1ABBV.MI) is 3 / 10.